Semaglutide is gaining traction as a groundbreaking treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and reducing glucagon production. Furthermore, semaglutide possesses potential effects beyond diabetes management, including weight loss and

Semaglutide has gained significant traction in recent years as a medication for treating type 2 diabetes and obesity. This effective glucagon-like peptide-1 (GLP-1) receptor agonist works by mimicking the effects of a naturally occurring hormone in the body, promoting blood sugar control . Understanding how semaglutide functions is important for i